A Study of Anti-IL-6R mAb Injection in Patients With iMCD

Clinical trial NCT05345522 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05345522
Sponsor: Beijing VDJBio Co., LTD.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Multicentric Castleman's Disease

Start date: 2022-04-18
Primary completion: 2022-11-27
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.